Abrilada
Payments companies reported to CMS as associated with Abrilada. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Abrilada, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Abrilada
These are the largest totals companies reported as associated with Abrilada. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alvin Wells | Destin, FL | Rheumatology | $6,470.08 |
| David Rubin | Chicago, IL | Gastroenterology (Internal Medicine) | $5,440.00 |
| Roy Fleischmann | Dallas, TX | $5,425.00 | |
| Peter Higgins | Ann Arbor, MI | Gastroenterology (Internal Medicine) | $5,120.00 |
| Jessica Allegretti | Boston, MA | Gastroenterology (Internal Medicine) | $3,700.00 |
| Jonathan Kay | Worcester, MA | Rheumatology | $3,000.00 |
| Ara Dikranian | San Diego, CA | Rheumatology | $2,000.00 |
| Madelaine Feldman | Metairie, LA | Rheumatology | $1,850.00 |
| John Tesser | Phoenix, AZ | Rheumatology | $1,700.00 |
| Catherine Bakewell | Salt Lake City, UT | Rheumatology | $1,600.00 |
Prescribed Abrilada?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.